stoxline Quote Chart Rank Option Currency Glossary
  
IDEXX Laboratories, Inc. (IDXX)
575.495  5.625 (0.99%)    02-27 15:05
Open: 569.61
High: 576.57
Volume: 133,607
  
Pre. Close: 569.87
Low: 567.67
Market Cap: 47,818(M)
Technical analysis
2024-02-27 2:45:29 PM
Short term     
Mid term     
Targets 6-month :  677.06 1-year :  790.81
Resists First :  579.67 Second :  677.06
Pivot price 566
Supports First :  536.63 Second :  510.01
MAs MA(5) :  569.5 MA(20) :  557.63
MA(100) :  500.24 MA(250) :  492.11
MACD MACD :  9.1 Signal :  8.3
%K %D K(14,3) :  87 D(3) :  85.5
RSI RSI(14): 60.4
52-week High :  579.67 Low :  372.5
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ IDXX ] has closed below upper band by 21.1%. Bollinger Bands are 47.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 576.62 - 579.56 579.56 - 581.82
Low: 559.49 - 562.6 562.6 - 564.98
Close: 564.97 - 570.16 570.16 - 574.14
Company Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Headline News

Mon, 26 Feb 2024
IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mon, 26 Feb 2024
Fmr LLC Has $138 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - AmericanBankingNEWS

Sun, 25 Feb 2024
TimesSquare Capital Management LLC Buys 40592 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat

Sat, 24 Feb 2024
Let The Numbers Speak for Themselves: Analysis of Idexx Laboratories, Inc. (IDXX) Financial Report - MarketBeat

Thu, 22 Feb 2024
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch

Thu, 22 Feb 2024
Can IDEXX Laboratories, Inc. (IDXX) Stock Rise to the Top of Healthcare Sector Thursday? - InvestorsObserver

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Diagnostics & Research
Shares Out 83 (M)
Shares Float 82 (M)
Held by Insiders 1.1 (%)
Held by Institutions 92.6 (%)
Shares Short 1,850 (K)
Shares Short P.Month 1,840 (K)
Stock Financials
EPS 10.09
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 17.87
Profit Margin 23 %
Operating Margin 27.2 %
Return on Assets (ttm) 22.8 %
Return on Equity (ttm) 80.7 %
Qtrly Rev. Growth 8.8 %
Gross Profit (p.s.) 0
Sales Per Share 44.04
EBITDA (p.s.) 14.56
Qtrly Earnings Growth 12.1 %
Operating Cash Flow 907 (M)
Levered Free Cash Flow 694 (M)
Stock Valuations
PE Ratio 57.01
PEG Ratio 4.2
Price to Book value 32.17
Price to Sales 13.06
Price to Cash Flow 52.73
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android